Why Maggot Debridement has been a bustPosted by Mrudula Anil Karmarkar on May 10th, 2021 The global maggot debridement market size is expected to reach USD 19.1 million by 2027, expanding at a CAGR of 9.8%, according to a new report by Grand View Research, Inc. The rising investment in research and development, growing prevalence of chronic diseases, and the increasing number of burn cases are the key driving factors for the market. In the recent past, there has been a rise in the number of surgical procedures across the globe. Rising prevalence of chronic diseases, such as cancer, diabetes, and autoimmune diseases, is one of the key factors leading to an increase in the number of surgeries being performed in the country. The incidence of infectious and non-communicable diseases has increased over the past few decades. This can be attributed to factors such as urbanization, borderline poverty in most developing states, antimicrobial resistance, and rising prevalence of food-borne diseases. An unhealthy lifestyle, lack of physical activity, alcohol abuse, and smoking are some of the major factors contributing to the rising prevalence of the abovementioned diseases. According to CDC estimates, in 2017, more than 100.0 million people were living with diabetes in the U.S. Type II diabetes is the most common type of diabetes and 90.0% of the affected population is suffering from type II diabetes. Diabetic foot ulcer, a common complication of diabetes, typically requires wound debridement and surgical intervention to prevent foot amputation. Thus, a rising number of chronic wounds are anticipated to increase the demand for maggot debridement. Cancer has been a global healthcare burden as it is one of the leading causes of death. According to estimates by WHO, cancer is the leading cause of death globally and almost one in six deaths occur due to cancer. In addition, over 70.00% of cancer-related deaths occur in middle- and low-income countries. Owing to the rising prevalence of chronic conditions, the demand for maggot debridement therapy has also increased. Maggot Debridement Market Report Highlights
Increasing incidence of burns, trauma events, and road accidents across the globe is anticipated to drive the market for maggot debridement. For instance, according to WHO (2018), approximately 1,000,000 people in India suffer from severe or moderate burn every year. In addition, as per the NCBI, in 2017, countries such as Finland, the Netherlands, Bulgaria, China, Australia, and the U.K. reported a rise in the incidence of burn wounds. Furthermore, according to the American Association for the Surgery of Trauma, in 2017, around 1.2 million people died globally, and road accidents account for around 3,242 deaths per day. Road accidents mostly occur in middle- or low-income countries. Biomaterials and skin substitutes are majorly used for healing all kinds of burn wounds. Thus, a rising number of accidents is expected to boost the demand for products, which is expected to lead to considerable growth of the market for maggot debridement over the forecast period. The chronic wound segment held the largest revenue share of 60.2% in 2020 in the market for maggot debridement. The segment is anticipated to witness significant growth over the forecast period. Maggot debridement is majorly used in the treatment of chronic wounds. The chronic wounds comprise of diabetic foot ulcers, venous leg ulcers, and pressure ulcers. The pressure ulcer segment is anticipated to witness the fastest growth rate over the forecast period. Pressure ulcers are also known as bed sores and usually occur due to prolonged intense pressure on the skin. Prolonged hospital stay is the most common cause of such ulcers. Pressure ulcers are common in the geriatric population. Pressure ulcers generally occur at the bony areas of the body such as ankles, hips, and tailbone. Rising geriatric population across the globe is a major factor driving the segment. Have a Query? Ask Our Expert: https://www.grandviewresearch.com/inquiry/450818/ibb The biobags segment held the largest revenue share of around 76.3% in 2020 in the market for maggot debridement. The segment is anticipated to witness significant growth over the forecast period. This is owing to the rising prevalence of chronic wounds and an increasing number of surgeries across the globe. Biobags are comparatively safer to use and provide results in 28 days. It is the first contained biosurgical dressing approved by the Food and Drug Administration (FDA). Key companies are stressing on research and development to develop technologically advanced products to gain a competitive edge. Maggot debridement therapy is the future technique of wound debridement and researchers are continuously developing various techniques for safer, quicker, and easier wound debridement therapies. Some of the prominent players in the maggot debridement market include:
Grand View Research has segmented the global maggot debridement market on the basis of administration, application, end-use: Maggot Debridement Administration Outlook (Revenue, USD Million, 2016 - 2027)
Maggot Debridement Application Outlook (Revenue, USD Million, 2016 - 2027)
Maggot Debridement End-use Outlook (Revenue, USD Million, 2016 - 2027)
About Grand View Research Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare. For More Information:www.grandviewresearch.com Like it? Share it! More by this author |